Effective Absorption Modeling in Relative Bioavailability Study Risk Assessment
Journal Title: The AAPS Journal - Year 2012, Vol 14, Issue 4
Abstract
Absorption modeling is an excellent strategic fit to perform a risk assessment for relative bioavailability (RBA) studies as it provides direct input into the question that is at the core of the RBA decision, namely, how does the absorption of the test drug product compare to the reference and is it likely to be different enough to justify an RBA study. The main limitation to absorption modeling in risk assessment is the inherent uncertainty associated with modeling. The extent to which the absorption modeling is integrated into the risk assessment should depend on the level of confidence in the modeling. It is difficult, however, to quantify the level of confidence on a case by case basis. The effective application of absorption modeling for RBA risk assessment therefore requires a general understanding of when modeling is expected to be reliable and also how to build reliability directly into the modeling. This paper describes a framework for effective modeling in RBA risk assessment that is based on four fundamental building blocks: (1) relate severity of drug product change and API properties to reliability of modeling, (2) use critical model variables to express the critical differences in the drug products, (3) generate a fraction-absorbed response surface expressed in terms of the critical model variables to evaluate the relative performance of the drug products, and (4) tie the first three building blocks together by following good model building practices that assure the highest quality model is built. The building blocks are demonstrated by a simple but common example of a change in solid state from free base to HCl salt.
Authors and Affiliations
John P. Rose
Keywords
Related Articles
- EP ID EP681281
- DOI 10.1208/s12248-012-9402-1
- Views 88
- Downloads 0
Next Generation Ligand Binding Assays—Review of Emerging Technologies’ Capabilities to Enhance Throughput and Multiplexing
The purpose of this manuscript is to provide a summary of the evaluation done by the Throughput and Multiplexing subteam on five emerging technologies: Single molecule array (Simoa™), Optimiser™, CyTOF&#x...
Enhancement of MHC-I Antigen Presentation via Architectural Control of pH-Responsive, Endosomolytic Polymer Nanoparticles
The online version of this article (doi:10.1208/s12248-014-9697-1) contains supplementary material, which is available to authorized users.
High Sensitivity RT-qPCR Assay of Nonlabeled siRNA in Small Blood Volume for Pharmacokinetic Studies: Application to Survivin siRNA
The online version of this article (doi:10.1208/s12248-015-9812-y) contains supplementary material, which is available to authorized users.
Solid Lipid Budesonide Microparticles for Controlled Release Inhalation Therapy
A solid lipid microparticle system containing budesonide was prepared by oil in water emulsification followed by spray drying. The solid lipid system was studied in terms of morphology, particle size distribution, crysta...
Identification of Two Novel, Potent, Low-Liability Antinociceptive Compounds from the Direct In Vivo Screening of a Large Mixture-Based Combinatorial Library
Synthetic combinatorial methods now make it practical to readily produce hundreds of thousands of individual compounds, but it is clearly impractical to screen each separately in vivo. We theorized that the direct in viv...